About us...
Santero therapeutics SRL is a spin-off of the Université Libre de Bruxelles (ULB) founded in 2021 by Professors Cédric Govaerts, PhD and Abel Garcia-Pino, PhD.
It is rooted in nearly 20 years of fundamental research in their respective laboratories and aims to enable the development of drugs with new modes of action to target highly resistant pathogens.
“The word Santero is a nod to my origins, as it refers to traditional healers in Cuban culture.”
“The biotech world is particularly active in Belgium, which is a real opportunity for us.”
Abel Garcia-Pino PhD is a leading scientist working on the study of bacterial survival under stress, antibiotic resistance and the development of new therapies against bacterial infections.
His research has been supported by various funding bodies in Belgium and abroad, and has benefited from an ERC grant.
He is a professor at the Université Libre de Bruxelles (ULB).
Cédric Govaerts PhD is a leading scientist in the field of antibiotic extrusion and the development of new therapies for cystic fibrosis.
His work has been supported by Belgian funding agencies and numerous foundations.
He is Professor at the Université Libre de Bruxelles (ULB) and Director of Research at the FNRS.
The founders
The Team
The Santero therapeutics team consists of some fifteen people. Its Board of Directors and Scientific Advisory Board are made up of leading figures in the fields of research and healthcare.
